57 studies found for:    CXCR4
Show Display Options
Rank Status Study
1 Not yet recruiting Correlation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 Months
Conditions: Autism Spectrum Disorder;   Prematurity
Intervention:
2 Active, not recruiting Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Biological: Anti-CXCR4 (BMS-936564);   Biological: Lenalidomide;   Biological: Dexamethasone;   Biological: Bortezomib
3 Recruiting Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor
Condition: Cancer
Intervention: Drug: 64-Cu-plerixafor
4 Completed Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients
Condition: Multiple Myeloma
Intervention: Drug: BKT140
5 Completed
Has Results
AMD 3100 for Treatment of Myelokathexis
Condition: Neutropenia
Intervention: Drug: AMD3100 or plerixafor
6 Not yet recruiting Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia
Condition: Chronic Myeloid Leukemia
Intervention: Drug: BL-8040
7 Recruiting CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
Condition: Large Reperfused ST-Elevation Myocardial Infarction
Interventions: Drug: POL6326;   Drug: Placebo
8 Unknown  The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
Conditions: Laryngeal Cancer;   Hypopharyngeal Cancer;   Metastasis
Intervention:
9 Active, not recruiting First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
Conditions: Acute Myelogenous Leukemia;   Diffuse Large B-Cell Leukemia;   Chronic Lymphocytic Leukemia;   Follicular Lymphoma
Intervention: Drug: BMS-936564 (Anti-CXCR4)
10 Completed A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.
Conditions: Acute Myeloid Leukaemia;   High Risk Myelodysplastic Syndrome
Interventions: Drug: Plerixafor;   Drug: AC220;   Drug: Ganetespib
11 Unknown  The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma
Condition: Oral Cancer
Intervention:
12 Completed Auto-immunity in Lupus Patients After Influenza Vaccine
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Drug: Vaccine
13 Unknown  Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"
Conditions: Acute Myelocytic Leukemia;   Acute Lymphocytic Leukemia
Intervention:
14 Terminated First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4
Condition: Healthy Volunteers
Interventions: Biological: ALX-0651;   Biological: Placebo
15 Completed Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients
Condition: HIV Infections
Intervention: Drug: AMD11070
16 Recruiting Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
Condition: Multiple Myeloma
Intervention:
17 Recruiting Prognostic Potential Cell Surface Marker and Pim-kinase in Patients With Hematologic Malignancies or Solid Tumors
Conditions: Solid Tumor;   Ovarian Cancer;   Non-small Cell Lung Cancer;   Chronic Lymphocytic Leukemia;   Burkitt's Lymphoma
Intervention:
18 Completed
Has Results
Multicenter, Safety Study Of Maraviroc
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection
Intervention: Drug: Maraviroc
19 Recruiting Idiopathic CD4 Lymphocytopenia
Condition: Idiopathic CD4 Lymphocytopenia
Interventions: Biological: Constitution of a biobank of frozen cells, plasma and serum samples;   Genetic: Genetic study
20 Active, not recruiting Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: G-CSF;   Drug: Plerixafor;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years